Highly cytotoxic copper(II) complexes with modified paullone ligands.
Michael F Primik1, Gerhard Mühlgassner, Michael A Jakupec
1Institute of Inorganic Chemistry, University of Vienna, Austria.
Inorganic Chemistry
|December 9, 2009
Summary
Novel copper(II) complexes demonstrate significant cytotoxicity against various human cancer cell lines. Complexes 3 and 4 show potent activity with IC(50) values in the nanomolar range, indicating potential as anticancer agents.
Area of Science:
- Coordination Chemistry
- Medicinal Chemistry
- Materials Science
Background:
- Copper complexes are explored for their diverse biological activities.
- Indolobenzazepine derivatives offer a scaffold for novel therapeutic agents.
Purpose of the Study:
- To synthesize and characterize novel copper(II) complexes with indolobenzazepine ligands.
- To evaluate the cytotoxic activity of these complexes against human cancer cell lines.
Main Methods:
- Synthesis of copper(II) complexes using copper(II) chloride or acetate and indolobenzazepine ligands.
- Characterization via NMR, IR, UV-Vis spectroscopy, ESI mass spectrometry, and X-ray crystallography.
- Cytotoxicity assays using CH1, A549, SW480, A2780, and A2780cisR cancer cell lines.
Main Results:
- Five novel copper(II) complexes were successfully synthesized and characterized.
- All evaluated compounds, particularly complexes 3 and 4, exhibited significant cytotoxicity.
- Complexes 3 and 4 displayed IC(50) values in the nanomolar range against tested cancer cell lines.
Conclusions:
- The synthesized copper(II) indolobenzazepine complexes possess potent anticancer properties.
- Complexes 3 and 4 represent promising candidates for further development as chemotherapeutic agents.
- The study highlights the potential of metal-based drugs in cancer treatment.
More Related Videos
![[(DPEPhos)(bcp)Cu]PF6: A General and Broadly Applicable Copper-Based Photoredox Catalyst](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F59739.jpg&w=3840&q=50)
Related Concept Videos
00:56Extraction: Advanced Methods
Metal ions can be separated from one another by complexation with organic ligands–the chelating agent– to form uncharged chelates. Here, the chelating agent must contain hydrophobic groups and behave as a weak acid, losing a proton to bind with the metal. Since most organic ligands used in this process are insoluble or undergo oxidation in the aqueous phase, the chelating agent is initially added to the organic phase and extracted into the aqueous phase. The metal-ligand complex is formed in...
02:51Metal-Ligand Bonds
The hemoglobin in the blood, the chlorophyll in green plants, vitamin B-12, and the catalyst used in the manufacture of polyethylene all contain coordination compounds. Ions of the metals, especially the transition metals, are likely to form complexes.
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
01:22EDTA: Chemistry and Properties
Polydentate ligands are most widely used in complexometric titrations because they form more stable complexes with the metal ions than mono- or bidentate ligands due to the chelate effect. Examples of polydentate ligands are ethylenediaminetetraacetic acid (EDTA), crown ethers, and cryptands. The most important feature of optimal polydentate ligands is the ability to form 1:1 complexes in a single-step process. Amino carboxylic acid derivatives are frequently used as complexing agents. EDTA is...
01:19Complexation Equilibria: The Chelate Effect
In complexation reactions, metal atoms or cations interact with ligands to form donor-acceptor adducts called metal complexes. Ligands that bind through one donor site are monodentate, ligands with two donor sites are bidentate, and those with more than two donor sites are polydentate ligands. For example, ethylene diamine is a bidentate ligand that binds through two nitrogen donor atoms, forming a five-membered ring. EDTA is a polydentate ligand that binds through four oxygen and two nitrogen...
00:43Complexometric Titration: Ligands
Different monodentate and polydentate ligands are used as complexing agents in complexometric titration reactions. The formation of complexes by mono- and bidentate ligands involves two or more intermediate steps, limiting their use as complexing agents. In comparison, polydentate ligands can form complexes with metal ions in a single-step process, facilitating sharper end points. This means polydentate ligands, such as amino carboxylic acid derivatives, are most commonly employed in...
01:26EDTA: Auxiliary Complexing Reagents
EDTA titrations are usually carried out in highly basic conditions, where the fully deprotonated form of EDTA, Y4−, actively complexes with the free metal ions in the solution. Several metal ions precipitate as hydrous oxide (hydroxides, oxides, or oxyhydroxides) under these conditions, lowering the concentration of free metal ions in the solution. For this reason, auxiliary complexing agents or ligands such as ammonia, tartrate, citrate, or triethanolamine are used in EDTA titrations to...